Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells

被引:28
|
作者
Ronchetti, A
Iezzi, G
Crosti, MC
Garancini, MP
Protti, MP
Bellone, M
机构
[1] Ist Sci H San Raffaele, Lab Immunol Tumori, I-20132 Milan, Italy
[2] Ist Sci H San Raffaele, Unita Immunochim, I-20132 Milan, Italy
[3] Ist Sci H San Raffaele, Unita Epidemiol, I-20132 Milan, Italy
[4] Ist Sci H San Raffaele, Canc Immunotherapy & Gene Therapy Program, I-20132 Milan, Italy
关键词
in vivo animal models; cancer immunity; RMA; ovalbumin; apoptosis;
D O I
10.1002/jlb.66.2.247
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although the mechanisms regulating recognition and phagocytosis of apoptotic cells by scavenger cells ape the subject of intense investigation, little is known about the fate of the antigens contained in apoptotic cells and the constraints defining their immunogenicity, We developed a model in C57BL/6 mice to evaluate whether phagocytosis of apoptotic tumor cells yielded antigens able to get access to the MHC class I pathway and activate a specific cytotoxic T lymphocyte response. Our results demonstrate that apoptotic tumor cells are antigenic in, vitro and can be immunogenic in vivo. Their immunogenicity depends on the number of cells used for immunization and the antigen-presenting cells involved in processing and presentation of antigens contained in the dying cells. The demonstration of the immunogenicity of apoptotic cells may have direct implications both in autoimmunity and cancer.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 50 条
  • [1] Cross-priming of T lymphocytes by apoptotic cells in vivo: Role of dendritic cells and cytokine balance
    Ronchetti, A
    Rovere, P
    Iezzi, G
    Galati, G
    Heltai, S
    Protti, MP
    Garancini, MP
    Manfredi, AA
    Rugarli, C
    Bellone, M
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 49 - 49
  • [2] Cytotoxic T lymphocytes and cross-priming
    Heath, WR
    Clarke, SMR
    Davey, GM
    Kurts, C
    Lew, AM
    Li, M
    Mintern, J
    Sutherland, RM
    Carbone, FR
    Miller, JFAP
    IMMUNOLOGIST, 2000, 8 (1-2): : 16 - 17
  • [3] Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells
    Latouche, JB
    Sadelain, M
    NATURE BIOTECHNOLOGY, 2000, 18 (04) : 405 - 409
  • [4] Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells
    Jean-Baptiste Latouche
    Michel Sadelain
    Nature Biotechnology, 2000, 18 : 405 - 409
  • [5] IFN-Producing Killer Dendritic Cells Are Antigen-Presenting Cells Endowed with T-Cell Cross-Priming Capacity
    Pletneva, Maria
    Fan, Hongni
    Park, Jang-June
    Radojcic, Vedran
    Jie, Chunfa
    Yu, Yanxing
    Chan, Camie
    Redwood, Alec
    Pardoll, Drew
    Housseau, Franck
    CANCER RESEARCH, 2009, 69 (16) : 6607 - 6614
  • [6] The role of B lymphocytes as antigen-presenting cells
    Chen, Xinjian
    Jensen, Peter E.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2008, 56 (02) : 77 - 83
  • [7] The role of B lymphocytes as antigen-presenting cells
    Xinjian Chen
    Peter E. Jensen
    Archivum Immunologiae et Therapiae Experimentalis, 2008, 56 : 77 - 83
  • [8] Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes
    Shao, Jie
    Xu, Qiuping
    Su, Shu
    Wei, Jia
    Meng, Fanyan
    Chen, Fangjun
    Zhao, Yang
    Du, Juan
    Zou, Zhengyun
    Qian, Xiaoping
    Liu, Baorui
    CELLULAR IMMUNOLOGY, 2018, 334 : 78 - 86
  • [9] IN-VITRO PRIMING OF CYTOTOXIC T-LYMPHOCYTES AGAINST POORLY IMMUNOGENIC EPITOPES BY ENGINEERED ANTIGEN-PRESENTING CELLS
    BELLONE, M
    IEZZI, G
    MANFREDI, AA
    PROTTI, MP
    DELLABONA, P
    CASORATI, G
    RUGARLI, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (11) : 2691 - 2698
  • [10] Generation of tumor specific T lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells
    Hoffmann, TK
    Meidenbauer, N
    Dworacki, G
    Kanaya, H
    Whiteside, TL
    CANCER RESEARCH, 2000, 60 (13) : 3542 - 3549